Shorter sleep duration may raise the risk for glaucoma and elevated IOP in patients with obstructive sleep apnea.

Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other ...

Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and ...

With more than 1 in 10 Americans suffering from obstructive sleep apnea putting them at increased risk of heart problems and ...

Magnesium depletion may be an independent risk factor for OSA, and magnesium depletion score may be a biomarker to identify those with OSA risk.

The doctors warned against screening tools, like questionnaires, found on the internet and apps that monitor sleep. 'None of ...

Vivos Therapeutics Inc. (NASDAQ:VVOS) saw its stock soar by 90% following a major regulatory win: the company’s VidaSleep ...

Investing.com -- Vivos Therapeutics Inc . (NASDAQ: VVOS) stock surged 90% after the company announced its VidaSleep oral appliance received approval from the Centers for Medicare & Medicaid Services ...

With more than 1 in 10 Americans suffering from obstructive sleep apnea putting them at increased risk of heart problems and other health ills, a new ...

Woodland Heights Medical Center is committed to helping patients get a better night's sleep, offering a surgical treatment ...

Expert Advice That Could Transform Your Health Doctor’s Day 2025 is not just a moment to celebrate the tireless dedication of ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.